According to IMARC Group’s latest report, titled “Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 40.25 Billion by 2027, exhibiting at a CAGR of 19.5% during 2022-2027.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/next-generation-sequencing-market/requestsample
Next-generation sequencing (NGS) refers to the technology used for determining the sequence of nucleotides in deoxyribonucleic acid (DNA) genomes. NGS studies the genetic variation in the samples of specific diseases or other biological phenomena. It is a cost-effective solution that enables the interrogation of multiple genes in a single sequencing run. As compared to traditional sequencing methods, NGS provides more accurate results with higher precision and speed. It also requires lower sample input, which facilitates research in personalized and genetic medicines, clinical diagnostics, and agriculture and animal studies.
Market Trends and Drivers:
The increasing prevalence of chronic ailments and the widespread adoption of genome mapping programs to predict disease development are majorly driving the global next-generation sequencing (NGS) market growth. Additionally, rapid technological innovations in sequencers, such as the large-scale integration with cloud-computing systems for improved data management, are contributing to the market growth. The introduction of such products has prompted competitive players to invest in research and development (R&D) activities to develop efficient and portable NGS systems, which is further catalyzing the market growth. Moreover, rising expenditure in sequencing chemistry, molecular biology, and technical engineering is creating a positive outlook for the market.
Next Generation Sequencing Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the next-generation sequencing (NGS) market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Eurofins Scientific
- Hoffmann-La Roche AG
- GenapSys Inc.
- Qiagen N.V.
- Oxford Nanopore Technologies
- Agilent Technologies
- 10x Genomics
- Thermo Fisher Scientific
- Becton Dickinson and Company
Key Market Segmentation:
The report has segmented the global next-generation sequencing (NGS) market on the basis of sequencing type, product type, technology, application, end-user and region.
Breakup by Sequencing Type:
- Whole Genome Sequencing
- Targeted Resequencing
- Whole Exome Sequencing
- RNA Sequencing
- CHIP Sequencing
- De Novo Sequencing
- Methyl Sequencing
Breakup by Product Type:
- Reagents and Consumables
- Software and Services
Breakup by Technology:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
Breakup by Application:
- Drug Discovery and Personalized Medicine
- Genetic Screening
- Agriculture and Animal Research
Breakup by End-User:
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/next-generation-sequencing-market
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Email: email@example.com Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
PR-Wirein, Reportedtimes, iCN Internal Distribution, Research Newswire, English